Your browser doesn't support javascript.
loading
Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital.
Barker-Haliski, Melissa; Knox, Kevin; Zierath, Dannielle; Koneval, Zachery; Metcalf, Cameron; Wilcox, Karen S; White, H Steve.
Affiliation
  • Barker-Haliski M; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Knox K; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Zierath D; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Koneval Z; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Metcalf C; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, USA.
  • Wilcox KS; Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, Utah, USA.
  • White HS; Department of Pharmacy, University of Washington, Seattle, Washington, USA.
Epilepsia ; 62(7): 1677-1688, 2021 07.
Article in En | MEDLINE | ID: mdl-34080183
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phenobarbital / Epilepsy, Temporal Lobe / Everolimus / Anticonvulsants Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Language: En Journal: Epilepsia Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Phenobarbital / Epilepsy, Temporal Lobe / Everolimus / Anticonvulsants Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Language: En Journal: Epilepsia Year: 2021 Type: Article Affiliation country: United States